<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04444544</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00536</org_study_id>
    <nct_id>NCT04444544</nct_id>
  </id_info>
  <brief_title>Quality of Life and High-Risk Abdominal Cancer Surgery</brief_title>
  <acronym>ChangeQoL</acronym>
  <official_title>Changes of Health-related Quality of Life After High-risk Oncological Abdominal Surgery; a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to measure the changes of health-related quality of life (HRQoL) at 6&#xD;
      months and 12 months after the following high-risk oncological abdominal surgery:&#xD;
      gastrectomy, esophagectomy, pancreatectomy and hepatectomy. The investigators will measure&#xD;
      the HRQoL using the validated EORTC QLQ-C30 questionnaire before and at 6 months and 12 month&#xD;
      after the surgery. The investigators will identify phenotypes of HRQoL changes (improvement,&#xD;
      stability and deterioration) at 6 months and 12 months after surgery.&#xD;
&#xD;
      The second aim is to assess the regret of the patient at 6 months and 12 months regarding&#xD;
      his/her decision to undergo surgery. The investigators will also assess the regret of the&#xD;
      next of kin at 6 months regarding the decision to undergo surgery.&#xD;
&#xD;
      This descriptive, prospective, observational, single-centre cohort study aims to: identify&#xD;
      phenotypes of HRQoL changes after abdominal surgical oncology (improvement, stability and&#xD;
      deterioration); assess the regret of patients regarding their decision to undergo surgical&#xD;
      oncology at 6 months and 12 months; assess the regret of the next of kin regarding the&#xD;
      decision of the patient to undergo surgical oncology at 6 months and 12 months. The&#xD;
      investigators will include patients scheduled for the following elective abdominal cancer&#xD;
      surgery: gastrectomy; esophagectomy; pancreas resection and hepatectomy. The investigators&#xD;
      will assess HRQoL using the validated EORTC QLQ-C30 Summary Score before and 6 months and 12&#xD;
      months after surgery. The cut-offs for the three phenotypes of HRQoL changes will be defined&#xD;
      using the minimal clinically important difference (MCID) of 10 points. The investigators will&#xD;
      assess regret using the Decision Regret Scale (DRS) at 6 months and 12 months after surgery.&#xD;
&#xD;
      The expected results are: The investigators can identify phenotypes of HRQoL changes after&#xD;
      surgical oncology using the EORTC QLQ-C30 Summary Score; the investigators will describe the&#xD;
      distribution of these phenotypes and will find an association with the pre-existing frailty.&#xD;
      The investigators can describe the extent of the regret of the patient and of the next of kin&#xD;
      at 6 months using the DRS. The investigators will observe an association between the DRS&#xD;
      score at 6 months and the HRQoL Summary Score change. The investigators will not observe a&#xD;
      relationship between the DRS score of patients and next-of-kins.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>EORTC-QLQ C30. Minimum 0, Maximum 100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Regret</measure>
    <time_frame>6 and 12 months after surgery</time_frame>
    <description>Decision Regret Scale. Minimum 0, Maximum 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>EORTC-QLQ C30. Minimum 0, Maximum 100</description>
  </secondary_outcome>
  <enrollment type="Anticipated">266</enrollment>
  <condition>Quality of Life</condition>
  <condition>Surgery</condition>
  <condition>Cancer</condition>
  <condition>Frailty</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Risk Abdominal Surgery</intervention_name>
    <description>Pancreatectomy, Esophagectomy, Gastrectomy and Hepatectomy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elective patients scheduled for high-risk abdominal cancer surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Adult patients (&gt;18 years) scheduled for the following elective abdominal cancer surgery&#xD;
        known for high one-year mortality4: gastrectomy; esophagectomy; pancreas resection and&#xD;
        hepatectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with inoperable tumours; i.e. some patients will be excluded at the time of&#xD;
             surgery if unexpected advanced tumour staging is confirmed intraoperatively (e.g.&#xD;
             peritoneal carcinomatosis or any other diagnosis without therapy).&#xD;
&#xD;
          -  Hepatectomy for metastasectomy&#xD;
&#xD;
          -  Mentally impaired patients (known diagnosis)&#xD;
&#xD;
          -  Psychotic diagnoses (i.e. schizophrenia)&#xD;
&#xD;
          -  Dementia (mini mental score (MMSE) &lt; 18)&#xD;
&#xD;
          -  Incapacity to understand the information sheet&#xD;
&#xD;
          -  Blindness (unable to perform the visual part of the mini-mental state examination)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julien Maillard, MD</last_name>
    <phone>0041787753730</phone>
    <email>julien.maillard@hcuge.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals of Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1206</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Maillard, MD</last_name>
      <phone>0041787753730</phone>
      <email>julien.maillard@hcuge.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>June 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Julien Maillard</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Quality of Life</keyword>
  <keyword>Surgery</keyword>
  <keyword>Regret</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

